646 related articles for article (PubMed ID: 11714695)
1. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
[TBL] [Abstract][Full Text] [Related]
2. Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes.
Hassel S; Schmitt S; Hartung A; Roth M; Nohe A; Petersen N; Ehrlich M; Henis YI; Sebald W; Knaus P
J Bone Joint Surg Am; 2003; 85-A Suppl 3():44-51. PubMed ID: 12925609
[TBL] [Abstract][Full Text] [Related]
3. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.
Ghosh-Choudhury N; Abboud SL; Nishimura R; Celeste A; Mahimainathan L; Choudhury GG
J Biol Chem; 2002 Sep; 277(36):33361-8. PubMed ID: 12084724
[TBL] [Abstract][Full Text] [Related]
4. Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily.
Knaus P; Sebald W
Biol Chem; 2001 Aug; 382(8):1189-95. PubMed ID: 11592400
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction.
Aoki H; Fujii M; Imamura T; Yagi K; Takehara K; Kato M; Miyazono K
J Cell Sci; 2001 Apr; 114(Pt 8):1483-9. PubMed ID: 11282024
[TBL] [Abstract][Full Text] [Related]
6. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
[TBL] [Abstract][Full Text] [Related]
7. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity.
Kawai S; Faucheu C; Gallea S; Spinella-Jaegle S; Atfi A; Baron R; Roman SR
Biochem Biophys Res Commun; 2000 May; 271(3):682-7. PubMed ID: 10814522
[TBL] [Abstract][Full Text] [Related]
8. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between bone morphogenetic protein and transforming growth factor-beta signaling is essential for exendin-4-induced insulin-positive differentiation of AR42J cells.
Yew KH; Hembree M; Prasadan K; Preuett B; McFall C; Benjes C; Crowley A; Sharp S; Tulachan S; Mehta S; Tei E; Gittes G
J Biol Chem; 2005 Sep; 280(37):32209-17. PubMed ID: 16020542
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor kappaB-independent bone morphogenetic protein/Smad signaling.
Chen S; Guttridge DC; Tang E; Shi S; Guan K; Wang CY
J Biol Chem; 2001 Oct; 276(42):39259-63. PubMed ID: 11500509
[TBL] [Abstract][Full Text] [Related]
12. Effect of the distribution and clustering of the type I A BMP receptor (ALK3) with the type II BMP receptor on the activation of signalling pathways.
Nohe A; Keating E; Underhill TM; Knaus P; Petersen NO
J Cell Sci; 2003 Aug; 116(Pt 16):3277-84. PubMed ID: 12829744
[TBL] [Abstract][Full Text] [Related]
13. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
14. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
[TBL] [Abstract][Full Text] [Related]
15. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).
Lin Y; Martin J; Gruendler C; Farley J; Meng X; Li BY; Lechleider R; Huff C; Kim RH; Grasser WA; Paralkar V; Wang T
BMC Cell Biol; 2002 Jun; 3():15. PubMed ID: 12097147
[TBL] [Abstract][Full Text] [Related]
16. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells.
Valdimarsdottir G; Goumans MJ; Rosendahl A; Brugman M; Itoh S; Lebrin F; Sideras P; ten Dijke P
Circulation; 2002 Oct; 106(17):2263-70. PubMed ID: 12390958
[TBL] [Abstract][Full Text] [Related]
18. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts.
Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS
Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420
[TBL] [Abstract][Full Text] [Related]
19. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation.
Ying SX; Hussain ZJ; Zhang YE
J Biol Chem; 2003 Oct; 278(40):39029-36. PubMed ID: 12871975
[TBL] [Abstract][Full Text] [Related]
20. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation.
Fujii M; Takeda K; Imamura T; Aoki H; Sampath TK; Enomoto S; Kawabata M; Kato M; Ichijo H; Miyazono K
Mol Biol Cell; 1999 Nov; 10(11):3801-13. PubMed ID: 10564272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]